Fangsheng Pharmaceutical
6039989.460.00% ( 0.00 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Fangsheng Pharmaceutical(603998) the Revenue is 462.77 M (+10.69%);the EBIT is 105.03 M (+19.67%);the EPS is 0.2 (+0%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.46B10.69%
----
----
EBIT
0.11B19.67%
----
----
EPS
0.2--
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf